Skip to Content
Merck
CN

46866

Sulfamoxole

VETRANAL®, analytical standard

Synonym(s):

4-Amino-N-(4,5-dimethyl-2-oxazolyl)benzenesulfonamide, N1-(4,5-Dimethyloxazol-2-yl)sulfanilamide

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C11H13N3O3S
CAS Number:
729-99-7
Molecular Weight:
267.30
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
329757254
EC Number:
211-982-7
Beilstein/REAXYS Number:
248434
MDL number:
MFCD00005303

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

analytical standard

Quality Level

200

product line

VETRANAL®

shelf life

limited shelf life, expiry date on the label

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

application(s)

clinical testing

format

neat

SMILES string

Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C

InChI

1S/C11H13N3O3S/c1-7-8(2)17-11(13-7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6H,12H2,1-2H3,(H,13,14)

InChI key

CYFLXLSBHQBMFT-UHFFFAOYSA-N

General description

Chemical structure: sulfonamide

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Other Notes

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Legal Information

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H317

Hazard Classifications

Skin Sens. 1

Storage Class

11 - Combustible Solids

wgk

WGK 2

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCC3608
BCBT9181

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

R N Grüneberg
Current medical research and opinion, 8(2), 128-133 (1982-01-01)
Chequerboard studies with sulfamoxole and trimethoprim against urinary pathogens showed that the combination was never antagonistic but usually showed little or no synergistic effect. An exception was with the inherently sulphonamide-resistant Strep. faecalis in which marked synergism (F.I.C. Index less
Comparative pharmacokinetics of co-trifamole and co-trimoxazole to 'steady state' in normal subjects.
I D Watson et al.
British journal of clinical pharmacology, 14(3), 437-443 (1982-09-01)
Zhanhui Wang et al.
International journal of molecular sciences, 13(5), 6334-6351 (2012-07-04)
A three-dimensional quantitative structure-activity relationship (3D-QSAR) model of sulfonamide analogs binding a monoclonal antibody (MAb(SMR)) produced against sulfamerazine was carried out by Distance Comparison (DISCOtech), comparative molecular field analysis (CoMFA), and comparative molecular similarity indices analysis (CoMSIA). The affinities of
I D Watson et al.
Clinical therapeutics, 4(2), 103-108 (1981-01-01)
In a randomized, crossover, multiple dose study, ten healthy volunteers received the recommended dosages of cotrimoxazole (80 mg trimethoprim and 400 mg sulfamethoxazole) and co-tri-famole (80 mg trimethoprim and 400 mg sulfamoxole) for five days each. Urinary levels of trimethoprim
J Dylewski et al.
The Journal of antimicrobial chemotherapy, 16(1), 103-109 (1985-07-01)
In a prospective blinded study, 135 men with genital ulcers culture positive for Haemophilus ducreyi, were randomized to one of three regimens. Two single dose regimens, either the combination of sulphamoxole 3200 mg/trimethoprim 640 mg or trimethoprim 700 mg alone
View All Related Papers

Global Trade Item Number

SKUGTIN
BOG00127-1G04061825134321
46866-25MG-R04061832358659

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service